Pancreatic Neoplasms: all 3,310 studies
Page 8 of 34. Open to participants first (910), then studies with results posted, then the rest; newest registration first within each.
- Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic CancerNot yet recruitingNCT05562297Phase 2
- Pre-planning Mathematical Models in EUS-guided Laser Ablation of Pancreatic LesionsRecruitingNCT05549960Not applicable
- NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)RecruitingNCT05529940Phase 3
- Austrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC)RecruitingNCT05526443
- PREOPANC-4 Implementation Program for Locally Advanced Pancreatic CancerRecruitingNCT05524090
- Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal AdenocarcinomaRecruitingNCT05518903Phase 2
- Compliance With ERAS Protocol in Pancreatic Surgery, Stress Response and OutcomesRecruitingNCT05518643
- Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical ResectionRecruitingNCT05517811
- Comparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion TrackerRecruitingNCT05501379
- sCD8, as a Novel Biomarker for Pancreatic CancerRecruitingNCT05500027
- Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic CancersRecruitingNCT05497531Not applicable
- Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic CancerRecruitingNCT05462496Phase 2
- Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)RecruitingNCT05451043Phase 2
- GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant AscitesRecruitingNCT05438459Phase 1/2
- Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for SurgeryRecruitingNCT05428358Not applicable
- Ablative Carbon Ion Radiotherapy With Pencil Beam Scanning for Locally Advanced Unresectable Pancreatic CancerRecruitingNCT05424159Not applicable
- Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid MalignanciesRecruitingNCT05417594Phase 1/2
- Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)RecruitingNCT05403177
- Chemical Profiling of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility StudyNot yet recruitingNCT05400408Not applicable
- GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual CareRecruitingNCT05391126Not applicable
- Profiling Program of Advanced/Metastatic Pancreatic Cancer PatientsRecruitingNCT05380414Not applicable
- Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASRecruitingNCT05379985Phase 1/2
- Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc AdenocarcinomaRecruitingNCT05376592
- Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 GeneRecruitingNCT05372614Phase 1
- Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine Chemotherapy for Pancreatic Cancer Peritoneal MetastasesRecruitingNCT05371223Phase 2
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseRecruitingNCT05366881
- Spleen Irradiation With Nanoliposomal Irinotecan Plus 5-FU and Leucovorin in Metastatic Pancreatic AdenocarcinomaRecruitingNCT05363007Phase 2
- Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Solid TumorsNot yet recruitingNCT05361954Phase 1
- Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD TrialRecruitingNCT05356117Not applicable
- Survival, Quality of Life and Resectability in Locally Advanced Pancreatic CancerRecruitingNCT05356039
- Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC)RecruitingNCT05346536Not applicable
- Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial)RecruitingNCT05298722Not applicable
- Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With CancerRecruitingNCT05297734Not applicable
- Surgery for Liver Metastases From PDACNot yet recruitingNCT05271110Not applicable
- A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid TumorRecruitingNCT05262491Phase 1
- Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic CancerRecruitingNCT05254171Phase 2/3
- Genetic, Microenvironmental, and Immunological Factors in Unresectable Pancreatic Ductal AdenocarcinomaRecruitingNCT05248750
- Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic SurgeryRecruitingNCT05245877Phase 4
- Phase 1 Study of MRTX1719 in Solid Tumors With MTAP DeletionRecruitingNCT05245500Phase 1
- Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic AdenocarcinomaRecruitingNCT05241249Phase 2
- AOH1996 for the Treatment of Refractory Solid TumorsRecruitingNCT05227326Phase 1
- Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic CancerRecruitingNCT05218889Phase 1/2
- Pharmacotyping of Pancreatic Patient-derived OrganoidsRecruitingNCT05196334
- Pancreatic Cancer Evolution Upon TreatmentRecruitingNCT05195281Not applicable
- Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic DiseasesRecruitingNCT05193162
- Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial)RecruitingNCT05191940Not applicable
- Triplex Checkpoint Inhibitors Therapy for Advanced Solid TumorsRecruitingNCT05187338Phase 1/2
- SHR6390 Plus Nab-paclitaxel and Gemcitabine in Advanced/Metastatic Pancreatic CancerNot yet recruitingNCT05185869Phase 2
- LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New TechnologyRecruitingNCT05184790
- PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPIRecruitingNCT05172310Phase 1
- Pancreatic Cancer & Surgical ResectionRecruitingNCT05170802
- Clinical Study of VG161 in Combination With Nivolumab in Subjects With Advanced Pancreatic CancerRecruitingNCT05162118Phase 1/2
- Prognostic Factors in Periampullary Tumors and CystsRecruitingNCT05155878
- Quality of Life of Pancreatic Cancer Patients:Psychometric Validation of Chinese Version in TaiwanRecruitingNCT05147168
- Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic CancerRecruitingNCT05132504Phase 2
- Monitoring and Managing Glucose Levels in People With Pancreatic CancerRecruitingNCT05132244Not applicable
- Evaluation of Resection Techniques for Pancreatic TumorsRecruitingNCT05128890
- Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.RecruitingNCT05102110
- Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic CancerRecruitingNCT05093231Phase 2
- Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic CancerRecruitingNCT05088889Phase 1
- Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic AdenocarcinomaRecruitingNCT05083247Phase 2
- MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid TumorsRecruitingNCT05076760Phase 1
- Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer PatientsRecruitingNCT05065801Phase 2
- Investigator-initiated Clinical Trial of MIKE-1RecruitingNCT05064618Phase 1/2
- Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid TumorsRecruitingNCT05053971Phase 1/2
- High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver MalignanciesRecruitingNCT05053555Not applicable
- ctDNA Assay in Patients With Resectable Pancreatic CancerRecruitingNCT05052671
- Peri-operative SLOG for Localized Pancreatic CancerRecruitingNCT05048524Phase 2
- Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic CancerRecruitingNCT05035147Phase 4
- Focused Ultrasound for the Treatment of Pancreatic Cancer - an International RegistryNot yet recruitingNCT05010226
- Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab AdizutecanRecruitingNCT05005403Phase 1
- Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell ManufacturingRecruitingNCT04981119
- Pancreatic Cancer Early Detection ConsortiumRecruitingNCT04970056
- Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICIRecruitingNCT04954599Phase 1/2
- EUS-CPN With and Without BupivacaineRecruitingNCT04951804Not applicable
- Spanish Series of Patients Treated With the Radionuclide Lutetium177RecruitingNCT04949282
- Organoid-Guided Chemotherapy for Advanced Pancreatic CancerRecruitingNCT04931381Phase 3
- Virtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesRecruitingNCT04907643Not applicable
- Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or Gemcitabine/Nab-Paclitaxel in MSS Pancreatic CancerNot yet recruitingNCT04901741Phase 2
- Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic CancerRecruitingNCT04894643Not applicable
- Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) MutationRecruitingNCT04890613Phase 1
- Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent TumorsNot yet recruitingNCT04889742Phase 2
- Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPCRecruitingNCT04855331Not applicable
- Gastric Venous Reconstruction After Total PancreatectomyNot yet recruitingNCT04850430Not applicable
- Preoperative Biliary Drainage in Malignant Biliary ObstructionNot yet recruitingNCT04847297
- Multicentered Prospective Randomized Controlled Trial For Solid Pancreatic LesionsRecruitingNCT04841616Not applicable
- Personalized Neoantigen Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant ChemotherapyRecruitingNCT04810910Phase 1
- Development of a Prediction Platform for Neoadjuvant Treatment and Prognosis in Pancreatic Cancer Using OrganoidNot yet recruitingNCT04777604
- Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer PatientsRecruitingNCT04751435Not applicable
- Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)RecruitingNCT04743479
- Development of a Prediction Platform for Adjuvant Treatment and Prognosis in Resected Pancreatic Cancer Using OrganoidRecruitingNCT04736043
- Microenvironment and Immunity of Digestive Cancers - East Paris Multicentric CohortNot yet recruitingNCT04707365Not applicable
- Endoscopic Ultrasound Radiofrequency Ablation, Database RepositoryEnrolling by invitationNCT04693754
- PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration SamplesRecruitingNCT04683315Phase 2
- A Trial of RSC-1255 for Treatment of Patients With Advanced MalignanciesRecruitingNCT04678648Phase 1
- Echo-endoscopy Biopsy Impact on the Circulating Tumor Cell LevelRecruitingNCT04677244Not applicable
- Resilience and Equity in Aging, Cancer, and Health (REACH)RecruitingNCT04674267Not applicable
- Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the PancreasRecruitingNCT04617457Phase 2
- Evaluating the Prognostic Capability of ctDNA as a Biomarker in Pancreatic Cancer Patients Undergoing Neoadjuvant ChemotherapyRecruitingNCT04616131
- Study of PRO in Patients With Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)RecruitingNCT04611867Not applicable